Cargando…
LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?
The world is seeking effective and safe weight-lowering drugs for centuries. LEAP2, acting on ghrelin and growth hormone secretagogue receptor, according to a study by Hageman et al.(1) in this issue of Cell Reports Medicine, found its way toward the next target of pharmacotherapy for obesity and re...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044093/ https://www.ncbi.nlm.nih.gov/pubmed/35492250 http://dx.doi.org/10.1016/j.xcrm.2022.100612 |